Latest Early-onset Alzheimer's disease Stories
A gene that raises the risk of Alzheimer's disease by at least 45 percent, and possibly higher, has been identified by New York scientists and an international team of gene hunters.
U.S. medical scientists say they have identified a gene that puts people at risk for developing Alzheimer's disease.
By Randolph E. Schmid Associated Press WASHINGTON -- Researchers have uncovered a new clue to the cause of Alzheimer's disease. The brains of people with the memory-robbing form of dementia are cluttered with a plaque made up of beta-amyloid, a sticky protein.
Researchers from Harvard Medical School have made what they believe to be a key discovery in the cause of Alzheimerâ€™s disease. Their research found that people who suffer from a form of dementia that affects memory have a certain type of plaque in their brains. The plaque is made up of a sticky protein known as beta-amyloid.
Heavy drinkers and heavy smokers develop Alzheimerâ€™s disease years earlier than people with Alzheimerâ€™s who do not drink or smoke heavily, according to research that will be presented at the American Academy of Neurology 60th Anniversary Annual Meeting in Chicago, April 12â€“19, 2008.
Researchers at the Buck Institute now believe that this normal memory loss is hyper-activated in Alzheimerâ€™s disease (AD) and that this effect is key to the profound memory loss associated with the incurable neurodegenerative disorder.
Researchers at the University of Washington in Seattle reported Monday that a personâ€™s risk of Alzheimerâ€™s disease jumps dramatically if both parents have the disease.
By Anthony J. Brown, MD NEW YORK (Reuters Health) - Women destined to be diagnosed with Alzheimer's disease often show a reduction in body weight many years before symptom onset, new research shows. However, men who develop this neurologic disorder do not show any weight changes.
CHICAGO (Reuters) - Sampling spinal fluid for a protein that makes up the plaques that clog the brains of Alzheimer's disease patients may help diagnose the mind-wasting disease, researchers said on Monday.
By Patricia Reaney LONDON (Reuters) - Substances in cerebrospinal fluid could be used to diagnose elderly people with early signs of Alzheimer's disease, scientists said on Monday.